Practical Pediatric HematologyAnupam Sachdeva Evidence-based medicine is the need of the hour. Every pediatrician strives for perfection is his or her practice. These are exciting times for Pediatric Hematology and Oncology. Major advances during the past decade in the field have enhanced the understanding and significantly influenced the management and outcome of many of these chronic and fatal diseases affecting children. While opportunities to learn decrease after one leaves the medical school, science keeps evolving. Keeping this in mind, Indian Academy of Pediatrics (IAP) envisaged starting specialty training under its plan of action 2006. Such trainings keep professional and residents updated about newly launched technologies and other advancements. This book is well illustrated and has many pictures and diagrams for the quick understanding of readers. This will be of use not only to the postgraduates of pediatrics but also will be of immense use to a general pediatrician as a ready-reckoner to be kept on the desk. |
From inside the book
Results 6-10 of 22
Page 35
... preterm infant has higher number of nucleated RBCs. Nucleated RBCs generally disappear by 3-4 days of life in term infants and 7-10 days in preterm infant. The persistence of nucleated RBCs beyond this period suggests the possibility of ...
... preterm infant has higher number of nucleated RBCs. Nucleated RBCs generally disappear by 3-4 days of life in term infants and 7-10 days in preterm infant. The persistence of nucleated RBCs beyond this period suggests the possibility of ...
Page 36
... preterm babies. One milliliter of blood represents about 1% of total blood volume in preterm babies. Removal of 8–10 ml of blood in a 1500 g baby constitutes 8% of the blood volume. Thus, excessive sampling should be avoided. Hemolytic ...
... preterm babies. One milliliter of blood represents about 1% of total blood volume in preterm babies. Removal of 8–10 ml of blood in a 1500 g baby constitutes 8% of the blood volume. Thus, excessive sampling should be avoided. Hemolytic ...
Page 38
... preterm baby, but are exaggerated. The response to anemia or hypoxia to hepatic erythropoietin synthesis in preterm baby is poor as compared to that in term baby. Frequent sampling, low level of hematopoietic growth factors such as ...
... preterm baby, but are exaggerated. The response to anemia or hypoxia to hepatic erythropoietin synthesis in preterm baby is poor as compared to that in term baby. Frequent sampling, low level of hematopoietic growth factors such as ...
Page 39
... cost is of concern. The criteria for transfusion of preterm infants are given in Table 5.5. Nutritional Anemia Neha Rastogi, Anupam Sachdeva, SP Yadav, Panna Choudhury. Fig. 5.1: Approach to neonatal anemia. Anemia in the Newborn 39.
... cost is of concern. The criteria for transfusion of preterm infants are given in Table 5.5. Nutritional Anemia Neha Rastogi, Anupam Sachdeva, SP Yadav, Panna Choudhury. Fig. 5.1: Approach to neonatal anemia. Anemia in the Newborn 39.
Page 40
Anupam Sachdeva. Table 5.5: Indications for small-volume RBC transfusions in preterm infants Transfuse infants at hematocrit <30% a. If receiving <35% supplemental hood oxygen b. If on continuous positive airway pressure (CPAP) or ...
Anupam Sachdeva. Table 5.5: Indications for small-volume RBC transfusions in preterm infants Transfuse infants at hematocrit <30% a. If receiving <35% supplemental hood oxygen b. If on continuous positive airway pressure (CPAP) or ...
Contents
Chapter21 | 156 |
Chapter22 | 165 |
Chapter23 | 178 |
Chapter24 | 181 |
Chapter25 | 199 |
Chapter26 | 208 |
Chapter27 | 232 |
Chapter28 | 247 |
Chapter09 | 69 |
Chapter10 | 75 |
Chapter11 | 85 |
Chapter12 | 90 |
Chapter13 | 97 |
Chapter14 | 115 |
Chapter15 | 120 |
Chapter16 | 125 |
Chapter17 | 130 |
Chapter18 | 144 |
Chapter19 | 148 |
Chapter20 | 153 |
Chapter29 | 259 |
Chapter30 | 262 |
Chapter31 | 266 |
Chapter32 | 272 |
Chapter33 | 281 |
Chapter34 | 289 |
Chapter35 | 298 |
Chapter36 | 305 |
Chapter37 | 309 |
Index | 313 |
Other editions - View all
Common terms and phrases
abnormalities acid activity acute adults antibodies anticoagulant antigen aplastic anemia APTT assay associated bleeding blood loss bone marrow transplantation catheter cause chemotherapy child childhood chronic clinical concentration congenital cytopenia decreased defects develop diagnosis disease disorders Disseminated intravascular coagulation donor dose drugs erythrocyte erythropoietin factor VIII ferritin fetal fibrin fibrinogen folate g/dl gene globin granulocytes Haematol hematocrit hematological hemoglobin hemolysis hemolytic anemia hemophilia hemorrhage heparin hepatitis immune increased India infants infection infusion inhibitor intravenous iron deficiency ischemic laboratory leukemia levels liver malignancy mutations myelodysplastic syndrome myeloid neonatal neutropenia newborn normal nutritional occur oral patients Pediatr peripheral plasma platelet platelet count platelet transfusion present preterm prophylaxis protein prothrombin red cell reticulocyte count risk serum severe splenectomy stem cell stroke studies syndrome Table thalassemia therapy thrombin thrombocytopenia thrombocytosis thrombosis tissue treatment usually venous viral virus vitamin